Photo from wikipedia
Use of bridging anticoagulation increases a patient's bleeding risk without clear evidence of thrombotic prevention among warfarin‐treated patients with atrial fibrillation. Contemporary use of bridging anticoagulation among warfarin‐treated patients with… Click to show full abstract
Use of bridging anticoagulation increases a patient's bleeding risk without clear evidence of thrombotic prevention among warfarin‐treated patients with atrial fibrillation. Contemporary use of bridging anticoagulation among warfarin‐treated patients with venous thromboembolism (VTE) has not been studied.
Keywords:
anticoagulation;
patients venous;
bridging anticoagulation;
venous thromboembolism;
periprocedural bridging
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!